We use cookies to collect and analyse information on site performance and usage to improve and customise your experience, where applicable. View our Cookies Policy. Click Accept and continue to use our website or Manage to review and update your preferences.

Strictly necessary cookies

Cookie name Duration Cookie purpose
ASP.NET_SessionId Session This cookie holds the current session id (OPPassessment only)
.ASPXANONYMOUS 2 Months Authentication to the site
LSI 1 Year To remember cookie preference for Law Society websites (www.lawsociety.ie, www.legalvacancies.ie, www.gazette.ie)
FTGServer 1 Hour Website content ( /CSS , /JS, /img )
_ga 2 Years Google Analytics
_gat Session Google Analytics
_git 1 Day Google Analytics
AptifyCSRFCookie Session Aptify CSRF Cookie
CSRFDefenseInDepthToken Session Aptify defence cookie
EB5Cookie Session Aptify eb5 login cookie

Functional cookies

Cookie name Duration Cookie purpose
Zendesk Local Storage Online Support
platform.twitter.com Local Storage Integrated Twitter feed

Marketing cookies

Cookie name Duration Cookie purpose
fr 3 Months Facebook Advertising - Used for Facebook Marketing
_fbp 3 months Used for facebook Marketing
‘Extra jab could mean higher legal risks’

26 Aug 2021 / covid-19 Print

‘Extra jab could mean higher legal risks’

EU countries may face increased legal risks if they decide to use booster shots of COVID-19 vaccines, the European Commission has told the Reuters news agency.

This is because the additional dose has not yet been recommended by the EU drugs regulator, the European Medicines Agency (EMA). The watchdog has said that more information is needed before it can back the use of booster shots.

Reuters says that eight European countries have decided to recommend the additional dose, and more than a dozen are set to make similar moves shortly.

Firms’ liability ‘modified’

“The responsibility to decide to include boosters in their vaccination campaign remains with the member states,” the commission said in a statement to the news agency.

“As long as the booster doses are not part of the marketing authorisation, companies’ liability is modified,” the EU body added.

This could mean that, in the event of unexpected side-effects that could be linked to boosters, EU states might bear the brunt of any legal consequences and compensation demands.

The commission stressed, however, that companies’ liability would not disappear entirely if boosters were administered without the EMA’s approval. For instance, if a side-effect after a booster was caused by manufacturing issues, the vaccine maker would remain liable for it.

Gazette Desk
Gazette.ie is the daily legal news site of the Law Society of Ireland